Laura Rosen, MD, PhD

Senior Vice President, Clinical Development

Laura Rosen, MD, PhD, has more than 20 years’ experience in Neuroscience R&D leading clinical development and translational medicine, and she joined Acumen as SVP of Clinical Development in 2025. Dr. Rosen started her industry career at Merck in 2003, where she was initially Neuroscience Franchise Lead in Clinical Pharmacology (Early Development) and later a Global Program Lead for numerous late-stage clinical programs.  From 2012-2016 she worked at Shire, the AZ “innovative medicines” (iMed) internal neuroscience biotech, and the small startup FLEX Pharma, before joining Takeda Pharmaceuticals, where she was initially Head of Translational Research & Early Clinical and later Head of Neuroscience Translational Medicine in the drug discovery unit.

Dr. Rosen completed her MD and PhD in molecular neurobiology at Harvard, her neurology residency at the University of Chicago, and post-doctoral training in AD at Brigham and Women’s Hospital.